Meiyan Liao
- Infectious Diseases top 2%
- Neurology top 2%
- Pulmonary and Respiratory Medicine top 10%
- Radiology, Nuclear Medicine and Imaging top 5%
- Oncology top 10%
- Topics
- Lung Cancer Diagnosis and Treatment (19 papers)Radiomics and Machine Learning in Medical Imaging (16 papers)COVID-19 Clinical Research Studies (8 papers)
- Journals
- SHILAP Revista de lepidopterologíaAnalytical ChemistryAmerican Journal of Kidney Diseases
- Partner nations
- ChinaUnited StatesSpain
In The Last Decade
Meiyan Liao
59 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Infectious Diseases 774
- Neurology 443
- Pulmonary and Respiratory Medicine 363
- Radiology, Nuclear Medicine and Imaging 332
- Oncology 257
Countries citing papers authored by Meiyan Liao
This map shows the geographic impact of Meiyan Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meiyan Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meiyan Liao more than expected).
Fields of papers citing papers by Meiyan Liao
This network shows the impact of papers produced by Meiyan Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meiyan Liao. The network helps show where Meiyan Liao may publish in the future.
Co-authorship network of co-authors of Meiyan Liao
This figure shows the co-authorship network connecting the top 25 collaborators of Meiyan Liao. A scholar is included among the top collaborators of Meiyan Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meiyan Liao. Meiyan Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 8 | |
| 6 | 6 | |
| 7 | 24 | |
| 8 | 68 | |
| 9 | 54 | |
| 10 | Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsiesbreakdown → | 645 |
| 11 | 114 | |
| 12 | 8 | |
| 13 | 9 | |
| 14 | 0 | |
| 15 | 6 | |
| 16 | 0 | |
| 17 | 46 | |
| 18 | 42 | |
| 19 | 6 | |
| 20 | 50 |
About Meiyan Liao
Meiyan Liao is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Neurology, having authored 64 papers that have together received 1.5k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (19 papers), Radiomics and Machine Learning in Medical Imaging (16 papers) and COVID-19 Clinical Research Studies (8 papers). The work is most often cited by research in Infectious Diseases (774 citations), Neurology (443 citations) and Critical Care and Intensive Care Medicine (86 citations). Meiyan Liao has collaborated with scholars based in China, United States and Spain. Frequent co-authors include Sufang Tian, Shu‐Yuan Xiao, Yong Xiong, Jianchun Guo, Huan Liu, Li Niu, Hanfei Zhang, Dongyong Zhu, Liying Xu and Yiyuan Cao. Their work appears in journals such as SHILAP Revista de lepidopterología, Analytical Chemistry and American Journal of Kidney Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.